Co-occurring AD associated amyloid-beta (Aβ) plaques and tau Neurofibrillary Tangles (NFTs) occur in 30-40% of patients with PD (Figure 1) and may contribute to clinical features of disease [22,23] Particularly Development of Dementia (PDD). Here, MAPT is linked to Parkinson disease.